Adita Bio Sys Profile
Key Indicators
- Authorised Capital ₹ 6.70 Cr
as on 16-11-2024
- Paid Up Capital ₹ 3.68 Cr
as on 16-11-2024
- Company Age 9 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.90 Cr
as on 16-11-2024
- Revenue -12.12%
(FY 2023)
- Profit 13.71%
(FY 2023)
- Ebitda 155.57%
(FY 2023)
- Net Worth 0.77%
(FY 2023)
- Total Assets 42.02%
(FY 2023)
About Adita Bio Sys
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.70 Cr and a paid-up capital of Rs 3.68 Cr.
The company currently has active open charges totaling ₹5.90 Cr.
Methuku Nagesh, Balagangadhara Channathimmaiah, and Shivarudraiah Prasad serve as directors at the Company.
- CIN/LLPIN
U85100KA2015PTC079003
- Company No.
079003
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Feb 2015
- Date of AGM
28 Jun 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Tumkur, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Adita Bio Sys?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Methuku Nagesh  | Director | 16-Jul-2024 | Current |
| Balagangadhara Channathimmaiah | Director | 16-Jul-2024 | Current |
| Shivarudraiah Prasad | Director | 16-Jul-2024 | Current |
Financial Performance and Corporate Structure Insights of Adita Bio Sys.
Adita Bio Sys Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 12.12% decrease. The company also saw a substantial improvement in profitability, with a 13.71% increase in profit. The company's net worth moved up by a moderate rise of 0.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adita Bio Sys?
In 2023, Adita Bio Sys had a public holding of 24.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 20 Mar 2023 | ₹1.30 M | Open |
State Bank Of India Creation Date: 30 Mar 2019 | ₹5.77 Cr | Open |
How Many Employees Work at Adita Bio Sys?
Adita Bio Sys has a workforce of 49 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adita Bio Sys, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adita Bio Sys's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
